a retrospective review of 39 primary ovarian tumors of different pathologic stages and classes , treated postoperatively with medroxyprogesterone acetate ( mpa , depo-provera , upjohn ) and in most cases melphalan , showed a high karnofsky performance index and good complete and partial response rates .
C0065864
medroxyprogesterone acetate
C0699700
depo-provera